Tumor necrosis factor alpha (TNF-a) is a prototypical proinflammatory cytokine that can elicit strong inflammation in macrophages by activating NF-jB. The underlying epigenetic mechanism is obscure. We show here that megakaryocytic leukemia 1 (MKL1) is an epigenetic mediator of TNF-ainduced proinflammatory transcription. Overexpression of a dominant negative form of MKL1 abrogates TNF-a-induced transactivation of proinflammatory genes. Proteomic analysis identifies the histone H3K4 trimethyltransferase ASH2 as a potential cofactor for MKL1. In response to TNF-a stimulation, ASH2 is recruited by MKL1 and interacts with MKL1 to catalyze H3K4 di-and trimethylation. ASH2 modulates proinflammatory transcription at least in part by altering the affinity of p65 for target promoters. Together, our data support an interplay between MKL1 and ASH2 to promote TNF-a-induced proinflammatory transcription in macrophages.
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Keywords: ASH2; epigenetics; macrophage; MKL1; TNF-a; transcriptional regulation Inflammation is an evolutionarily conserved process that helps fend off the invasion of harmful pathogens and protect the integrity of the host [1] . Excessive inflammation, however, is considered deleterious to the host and often associated with the pathogenesis of human diseases such as cancer and atherosclerosis [2, 3] . Macrophages are a major source of inflammation capable of regulating a series of pathophysiological processes in humans [4] . When exposed to stimuli, such as lipopolysaccharide (LPS), macrophages produce and secret a host of proinflammatory cytokines and chemokines including IL-1, IL-6, CCL2, and CCL5 to regulate systemic or regional inflammatory response. Dysregulated macrophage activation has been implicated in carcinogenesis, type 2 diabetes, fatty liver disease, and a number of cardiovascular disorders [5] . Epigenetic programming of myeloid cell function has been extensively investigated over the past decade or so with many groundbreaking findings, but large gaps exist in our understanding of this critical pathophysiological process [6] .
Tumor necrosis factor alpha (TNF-a) is a prototypical proinflammatory cytokine that plays an important role in macrophage activation and, by extension, tissue Abbreviatons BMDM, bone marrow-derived macrophages; DMEM, Dulbecco's modified Eagle's medium; DN, dominant negative; ELISA, enzyme-linked immune absorbance assay; KO, knockout; LPS, lipopolysaccharide; MKL1, megakaryocytic leukemia 1; MRTF-A, myocardin-related transcription factor A; SRF, serum response factor; TNF, tumor necrosis factor alpha; TNFR, TNF-a or its cognate receptor.
inflammation [7] . Monoclonal antibodies targeting TNF-a or its cognate receptor (TNFR) have been used with some success in the clinics to treat sepsis [8] , rheumatoid arthritis [9] , and inflammatory bowel disease [10] . Upon binding to TNFR, TNF-a promotes the assembly of several different signalosomes that could lead to inflammation, apoptosis, or necroptosis [11] . By virtue of activating NF-jB, TNF-a is able to stimulate the synthesis of multiple proinflammatory mediators including itself in macrophages [12] . The underlying epigenetic mechanism is not completely understood.
Megakaryocytic leukemia 1 (MKL1), also called myocardin-related transcription factor A (MRTF-A), is a transcriptional modulator initially identified as a cofactor for serum response factor (SRF) in smooth muscle and cardiac muscle cells [13] . MRTF-A contains several functional domains conserved among members of the MRTF family: an N-terminal RPEL domain that binds to the cytoskeleton blocking MRTF-A from entering the nucleus, a middle glutamine-rich domain that mediates the interaction between MRTF-A and various sequence-specific transcription factors (e.g., SRF), and a C-terminal transactivation domain that likely helps recruit epigenetic factors to stimulate transcription [14] . Previously, we have shown that MKL1 plays an essential role in mediating the effect of LPS in macrophages [15] . We provide new evidence here to show that MKL1 is indispensable for TNF-a-induced proinflammatory transcription in macrophages by interacting with the histone H3K4 trimethyltransferase ASH2.
Materials and methods

Cell culture
Human monocytic/macrophage-like cells (THP-1, ATCC) and human embryonic kidney fibroblast cells (HEK293, ATCC) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. Primary peritoneal macrophages and were isolated from wild-type or MKL1-deficient mice [16] ; cells from two to three mice of the same genotype were pooled together for one replicate of ChIP experiments. Primary human peripheral blood monocytes, from healthy donors (male, aged between 23 and 25) were isolated and differentiated as described before [17] 
Plasmids, transfection, and reporter assay
Expression constructs for MKL1, p65, ASH2, IjB superrepressor, shRNA targeting p65, as well as promoter constructs have been described before [15, [18] [19] [20] . siRNAs for MKL1 and ASH2 were purchased from Dharmacon. Transient transfections were performed with Lipofectamine LTX (Invitrogen, Carlsbad, CA, USA). Luciferase activities were assayed 24-48 h after transfection using a luciferase reporter assay system (Promega, Madison, WI, USA). All experiments were repeated three times.
Protein extraction, immunoprecipitation and mass spectrometry
Whole cell lysates were obtained by resuspending cell pellets in RIPA buffer with freshly added protease inhibitor tablet (Roche, Branford, CT, USA). FLAG-conjugated beads (M2, Sigma, St. Louis, MO, USA) were added to and incubated with lysates overnight. Precipitated immune complex was eluted with 39 FLAG peptide (Sigma). Alternatively, specific antibodies or preimmune IgGs were added to and incubated with cell lysates overnight before being absorbed by Protein A/G-plus Agarose beads. Eluates were separated by SDS/PAGE electrophoresis followed by silver staining. Distinctive bands were excised, trypsin digested, and analyzed by mass spectrometry.
ChIP and re-ChIP assay
ChIP assays were performed essentially as described before [21, 22] . Aliquots of lysates containing 200 lg of nuclear protein were used for each immunoprecipitation reaction with anti-MKL1 (sc-32909, Santa Cruz, Santa Cruz, CA, USA), anti-p65 (sc-109, Santa Cruz), anti-ASH2 (A300-489A, Bethyl Laboratories, Montgomery, TX, USA), antidimethylated H3K4 (07-030, Millipore/Upstate, Syracuse, NY, USA), and anti-trimethylated H3K4 (07-473, Millipore/Upstate). For re-ChIP, immune complexes were eluted with the elution buffer (1% SDS, 100 mM NaCO 3 ), diluted with the re-ChIP buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris pH 8. 
RNA extraction and real-time PCR
RNA was extracted using an RNeasy RNA isolation kit (Qiagen, Mansfield, MA, USA). Reverse transcriptase reactions were performed using a SuperScript First-strand synthesis system (Invitrogen). Real-time PCR reactions were performed on an ABI STEPONE Plus (Life Tech, Waltham, MA, USA) with primers and Taqman probes purchased from Applied Biosystems (Foster City, CA, USA). All experiments were repeated three times.
Enzyme-linked immune absorbance assay (ELISA)
Enzyme-linked immune absorbance assay (ELISA) was performed using supernatants collected from THP-1 cells to measure MCP-1 (Pierce, Rockford, IL, USA), IL-6, TNFa, and IL-1 (Ray Biotech, Norcross, GA, USA). All experiments were repeated three times.
Statistical analysis
One-way ANOVA with post-hoc Scheffe analyses were performed using an SPSS package (Armonk, NY, USA). P values less than .05 were considered statistically significant (*).
Results
MKL1 regulates TNF-a-induced proinflammatory transcription
To examine whether MKL1 could play a role in TNF-ainduced proinflammatory transcription in macrophages, we exploited a dominant negative (DN) MKL1 that lacks the C-terminal transactivation domain [23] . MKL1 DN has been shown to block the transactivation of smooth muscle contraction proteins by SRF/Myocardin [23] and adhesion molecules by NF-jB [18] . Overexpression of MKL1 DN abrogated the induction of promoter activities of several proinflammatory mediators, including TNF-a, IL-1, IL-6, and MCP-1, by TNF-a treatment (Fig. 1A) . Furthermore, induction of a generic jB reporter that contains two copies of the NF-jB binding motif by TNF-a was significantly downregulated by MKL1 DN (Fig. 1B) . We also examined the expression of endogenous genes under the influence of MKL1 DN; as shown in (Fig. 1E,F) . NF-jB is the master regulator of TNF-a-induced proinflammatory transcription [24] . Therefore, we investigated whether MKL1 mediates TNF-a-induced proinflammatory transcription via NF-jB. Overexpression of MKL1 DN blocked the transactivation of the same set of proinflammatory genes by p65 in HEK293 cells ( Fig. 2A) . We also showed that overexpression of a constitutively active IjB (IjB SR) neutralized the activation of proinflammatory transcription by MKL1 despite the presence of TNF-a (Fig. 2B) . Direct silencing of p65 by shRNA also negated the effect of MKL1 on proinflammatory gene promoters (Fig. 2C) . Finally, mutagenesis of the NF-jB binding sites (jB mutant) on the proinflammatory gene promoters rendered MKL1 inactive (Fig. 2D) . Taken together, these data suggest that MKL1 may play an essential role in ). mRNA (E) and protein (F) levels of proinflammatory mediators were measured by qPCR and ELISA. All experiments, performed in triplicate wells, have been repeated at least three times. A representative replicate is shown. *P < 0.05.
TNF-a induced proinflammatory transcription in an NF-jB/p65-dependent manner.
MKL1 regulates histone H3K4 methylation by interacting with ASH2
MKL1 regulates transcription by forging extensive dialogues with the epigenetic machinery [25] . Indeed, ChIP assays found that compared to primary peritoneal macrophages isolated from Mkl1 +/+ mice, there was a decrease in histone H3K4 dimethylation (Fig. 3A) and trimethylation (Fig. 3B) , two prominent markers of gene transactivation [26] , surrounding the promoter regions of proinflammatory genes in macrophages isolated from Mkl1 À/À mice, suggesting that MKL1 might interact with the cellular histone H3K4 methyltransferase apparatus. In an attempt to identify such factor(s) involved in H3K4 methylation that could potentially interact with MKL1, we performed the following experiment. HEK293 cells were transfected with either FLAG-tagged MKL1 expression construct or an empty vector followed by immunoprecipitation using an anti-FLAG antibody. Eluted immune complex was separated by SDS/PAGE gel electrophoresis and distinct bands were cut, digested, and identified by mass spectrometry. As shown in Fig. 3C , among the proteins associated with FLAG-MKL1 was ASH2, a core component of the mammalian histone methyltransferase complex [27] . Coimmunoprecipitation assay performed in THP-1 cells using an anti-MKL1 antibody confirmed the interaction between MKL1 and ASH2 (Fig. 3D) . More important, re-ChIP assays found that TNF-a stimulated the interaction between MKL1 and ASH2 on the promoter regions, but not on the intron regions, of the proinflammatory mediator genes in THP-1 cells (Fig. 3E) . We conclude that MKL1 regulates histone H3K4 methylation possibly by interacting with ASH2. ) for 6 h. Re-ChIP assays were performed with indicated antibodies. All experiments, performed in triplicate wells, have been repeated at least three times. A representative replicate is shown. *P < 0.05. ). Cells were harvested at indicated time points and ChIP assays were performed with anti-NF-jB/p65. All experiments, performed in triplicate wells, have been repeated at least three times. A representative replicate is shown. *P < 0.05.
MKL1 recruits ASH2 to activate TNF-a-induced proinflammatory transcription
We performed additional experiments to verify the functional relevance of the MKL1-ASH2 interplay. In response to TNF-a stimulation, ASH2 was recruited to the promoter regions, but not to the intron regions, of the proinflammatory mediator genes in primary human peripheral blood macrophages (Fig. 4A) . ASH2 recruitment was dependent on MKL1 because MKL1 depletion by siRNA abrogated the binding of ASH2 on the gene promoters (Fig. 4B) . In reporter assays, ASH2 overexpression enhanced the transactivation of several proinflammatory gene promoters by MKL1 in the presence of TNF-a in a dose-dependent manner (Fig. 4C) . In addition, ASH2 also promoted the transactivation of a generic jB reporter by MKL1 (Fig. 4D) . The ability of ASH2 to activate the jB reporter was strictly reliant on MKL1 as evidenced by the observation that there was little activation of the jB reporter by ASH2 in mouse embryonic fibroblast (MEF) cells isolated from MKL1 KO mice; replenishment of MKL1 restored the ability of ASH2 to activate the jB reporter (Fig. 4E) . Collectively, these data suggest that MKL1 recruits ASH2 to activate TNF-a-induced proinflammatory transcription.
ASH2 regulates TNF-a-induced proinflammatory transcription by modulating NF-jB activity
We then assessed the role of ASH2 in TNF-ainduced proinflammatory transcription and the underlying mechanism. Depletion of ASH2 using siRNA (Fig. 5A for knockdown efficiency) significantly downregulated TNF-a-induced expression of proinflammatory mediators at both mRNA (Fig. 5B) and protein (Fig. 5C ) levels. Consistent with its role as a histone methyltransferase, we found that induction of H3K4 dimethylation (Fig. 5D ) and trimethylation (Fig. 5E ) surrounding the proinflammatory mediators was dampened without ASH2. We then tackled whether the binding of NF-jB/p65 to target promoters would be weakened by ASH2 depletion. Indeed, ChIP assay showed that in the absence of ASH2, the kinetics of p65 binding was altered such that it peaked later and/or declined faster compared to the control group (Fig. 5F ). We therefore propose that ASH2 may participate in the regulation of TNF-ainduced proinflammatory transcription by modulating NF-jB activity.
Discussion
Although LPS and TNF-a signal through distinct signaling pathways in macrophages, our data as published previously [15] and as summarized here suggest that a conserved epigenetic mechanism that involves MKL1-dependent histone H3K4 methylation underscores the transactivation of proinflammatory mediators. Our proteomic analysis identified ASH2, a core component of the H3K4 methyltransferase complex (COMPASS), as a novel binding partner for MKL1. Indeed, ASH2 contributes to TNF-a-induced proinflammatory transcription in macrophages in an MKL1-dependent manner. It is noteworthy that multiple epigenetic factors have been implicated in TNF-ainduced proinflammatory transcription. For instance, induction of E-selectin (Sele), an NF-jB target, in vascular endothelial cells, by TNF-a is accompanied by progressive recruitment of histone modifying enzymes and accumulation of active histone modifications on the Sele promoter although it is not clear how the recruitment of various epigenetic factors is coordinated [28] . Coactivator-associated arginine methyltransferase 1, or CARM1, promotes TNF-a-induced transactivation of a host of proinflammatory mediators by methylating histone H3R17 [29] . Although we show here that H3K4 methylation catalyzed by ASH2 plays a role in TNF-a-induced proinflammatory transcription, there are several caveats that need to be taken into consideration when interpreting the data. First, H3K4 methylation is programmed by multiple catalytic and noncatalytic factors. Li et al. [30] have shown that histone methyltransferase SET7/9 contributes to TNFa-induced transcription of MCP-1 by promoting sitespecific histone H3K4 trimethylation in macrophages, similar to what we have shown for ASH2. This observation has been further corroborated by Fujimaki et al. [31] who showed that SET7/9 regulates TNF-ainduced transactivation of iNOS, another NF-jB target, in islet b cells. Various studies have also placed MLL4 [32] or MLL1 [33] at the center of proinflammatory transcription in macrophages. Of note, ASH2 is the core component of the large methyltransferase complexes that selectively use modular catalytic subunits (e.g., SET7/9 or MLL1) [27] . Therefore, our data reaffirm that histone H3K4 methylation, regardless of the specific enzymes that actually carry out the catalysis, is essential for TNF-a-induced proinflammatory transcription in macrophages. Second, locus-specific H3K4 methylation levels are controlled not only by methyltransferases, but also by demethylases as well. Several reports have portrayed different H3K4 demethylases, including LSD1 and JARID1, as regulators of inflammatory response in macrophages [34, 35] . It is possible that MKL1 may block the access of or expel, in addition to ASH2 recruitment, demethylases from the promoters of proinflammatory genes. Finally, H3K4 methylation is only part of the epigenetic machinery that contributes to the transactivation of proinflammatory genes. Smales and colleagues have demonstrated that Brg1, the enzyme component of the chromatin remodeling complex, is involved in the transactivation of proinflammatory genes [36] . Loss of the repressive histone modifications, such as H3K9 methylation [37] and H3K27 methylation [38] , has also been implicated in this process. The most likely scenario is that multiple epigenetic factors, histone modifying enzymes included, collaborate to mediate TNF-ainduced proinflammatory transcription. Further studies are warranted to clarify the role of MKL1 as a potential coordinator moderating the epigenetic crosstalk.
One should take caution, however, when trying to interpret the data presented here as we only show a correlative, instead of a causative, relationship between ASH2-mediated H3K4 methylation and NF-jBmediated proinflammatory transcription. This caveat is further confounded by the fact that part of our conclusion was drawn from reporter assays. It remains controversial whether epiosomal reporter plasmids can be fully chromatinized to simulate in vivo transcription and as such be exploited as a reliable tool to investigate histone modification-based regulatory mechanisms [39] . Additional studies are warranted to solve this issue.
Mounting evidence suggests that MKL1 serves as a critical link between the epigenetic machinery and sequence-specific transcription factors. Our data as documented here show that MKL1 regulates TNF-a-induced proinflammatory transcription in an NF-jB-dependent manner (Fig. 2) and that NF-jB activity is reciprocally modulated by MKL1 likely through ASH2 recruitment and consequently H3K4 methylation (Fig. 5F ). This is consistent with previous reports demonstrating that MKL1 regulates transcription by interacting with histone acetyltransferase [40, 41] , histone demethylase [42] , and chromatin remodeling proteins [43, 44] . A recent study has found that an MKL1 inhibitor (CCG-1423) attenuates the inflammatory response in a mouse model of airway injury although it remains unclear whether the effect was directly mediated via MKL1 [45] . It would be of great interest to determine whether CCG-1423 could antagonize the inflammatory response in other models of human disease because such efforts could potentially validate MKL1 as a central mediator of cellular inflammation.
